Aemetis Gelecekteki Büyüme

NasdaqGM:AMTX - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (USD Millions )
Tarih	Gelir	Kazançlar	Serbest Nakit Akışı	Faaliyetlerden Nakit	Avg. Analist Sayısı
12/31/2026	740	61	-96	150	3
12/31/2025	463	-33	-184	34	4
12/31/2024	309	-94	-52	-19	3
9/30/2024	291	-97	-14	14	N/A
6/30/2024	279	-48	-20	12	N/A
3/31/2024	257	-44	-14	15	N/A
12/31/2023	187	-46	-19	14	N/A
9/30/2023	183	-43	-56	-27	N/A
6/30/2023	186	-141	-57	-30	N/A
3/31/2023	207	-116	-63	-26	N/A
12/31/2022	257	-108	-62	-23	N/A
9/30/2022	254	-86	-54	-17	N/A
6/30/2022	232	-37	-45	-9	N/A
3/31/2022	221	-47	-44	-15	N/A
12/31/2021	212	-47	-47	-21	N/A
9/30/2021	185	-61	-48	-25	N/A
6/30/2021	176	-55	-44	-21	N/A
3/31/2021	169	-43	-36	-12	N/A
12/31/2020	166	-37	-17	2	N/A
9/30/2020	180	-29	-12	6	N/A
6/30/2020	197	-23	-12	4	N/A
3/31/2020	200	-38	-10	1	N/A
12/31/2019	202	-36	-11	-2	N/A
9/30/2019	189	-40	-10	-3	N/A
6/30/2019	176	-40	-8	-5	N/A
3/31/2019	170	-32	-11	-8	N/A
12/31/2018	172	-33	-10	-6	N/A
9/30/2018	172	-30	-9	-6	N/A
6/30/2018	166	-32	N/A	-5	N/A
3/31/2018	162	-32	N/A	-6	N/A
12/31/2017	150	-30	N/A	-9	N/A
9/30/2017	149	-23	N/A	-6	N/A
6/30/2017	149	-20	N/A	-4	N/A
3/31/2017	141	-19	N/A	-3	N/A
12/31/2016	143	-16	N/A	0	N/A
9/30/2016	141	-21	N/A	2	N/A
6/30/2016	140	-22	N/A	2	N/A
3/31/2016	145	-24	N/A	2	N/A
12/31/2015	147	-27	N/A	-1	N/A
9/30/2015	153	-24	N/A	-4	N/A
6/30/2015	163	-18	N/A	-2	N/A
3/31/2015	182	-9	N/A	8	N/A
12/31/2014	208	7	N/A	21	N/A
9/30/2014	220	14	N/A	26	N/A
6/30/2014	229	5	N/A	23	N/A
3/31/2014	219	-7	N/A	14	N/A
12/31/2013	178	-24	N/A	-2	N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: AMTX önümüzdeki 3 yıl içerisinde kârlı hale gelmesi öngörülüyor; bu da tasarruf oranından ( 2.6% ) daha hızlı bir büyüme olarak değerlendiriliyor.

Kazançlar ve Piyasa: AMTX önümüzdeki 3 yıl içerisinde karlı hale gelmesi öngörülüyor ki bu da ortalama piyasa büyümesinin üzerinde kabul ediliyor.

Yüksek Büyüme Kazançları: AMTX önümüzdeki 3 yıl içinde karlı hale gelmesi bekleniyor.

Gelir ve Pazar: AMTX şirketinin gelirinin (yıllık 31.1% ) US pazarından (yıllık 9% ) daha hızlı büyümesi öngörülüyor.

Yüksek Büyüme Geliri: AMTX şirketinin gelirinin (yıllık 31.1% ) yıllık 20% dan daha hızlı büyümesi öngörülüyor.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: AMTX 'un Özsermaye Getirisi'nin 3 yıl içinde yüksek olmasının öngörülüp öngörülmediğini belirlemek için yeterli veri yok

Aemetis Gelecekteki Büyüme

Future kriter kontrolleri 5/6

Anahtar bilgiler

Gelecekteki son büyüme güncellemeleri

Consensus EPS estimates fall by 92%

Forecast breakeven date pushed back to 2026

Price target increased by 9.3% to US$12.42

Price target increased by 8.8% to US$12.67

Price target increased by 10% to US$13.33

Aemetis, Inc. Resumes Operations at 65 MGY California Biofuel Plant After Completing Extensive Maintenance and Upgrades

Recent updates

Aemetis, Inc. to Report Q3, 2024 Results on Nov 12, 2024

Aemetis, Inc. (NASDAQ:AMTX) Soars 28% But It's A Story Of Risk Vs Reward

Aemetis: Low Cash Reserves With An Uphill Battle To Secure More Financing

Take Care Before Jumping Onto Aemetis, Inc. (NASDAQ:AMTX) Even Though It's 25% Cheaper

Aemetis, Inc. to Report Q2, 2024 Results on Aug 01, 2024

Investors Give Aemetis, Inc. (NASDAQ:AMTX) Shares A 25% Hiding

Aemetis: Getting Ready For Breakout Growth

Aemetis, Inc. to Report Q1, 2024 Results on May 09, 2024

Aemetis, Inc., Annual General Meeting, May 29, 2024

Aemetis, Inc. announced delayed annual 10-K filing

Consensus EPS estimates fall by 92%

Forecast breakeven date pushed back to 2026

Full year 2023 earnings released: US$1.22 loss per share (vs US$3.12 loss in FY 2022)

Aemetis, Inc. to Report Q4, 2023 Results on Mar 07, 2024

Aemetis: Counting On The Potential

Price target increased by 9.3% to US$12.42

Price target increased by 8.8% to US$12.67

Cautious Investors Not Rewarding Aemetis, Inc.'s (NASDAQ:AMTX) Performance Completely

Third quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Aemetis, Inc. to Report Q3, 2023 Results on Nov 09, 2023

Independent Director recently sold US$85k worth of stock

Aemetis, Inc. Appoints J. Michael Rockett as Executive Vice President, General Counsel and Corporate Secretary

Price target increased by 10% to US$13.33

Aemetis, Inc. to Report Q2, 2023 Results on Aug 03, 2023

Aemetis, Inc. Resumes Operations at 65 MGY California Biofuel Plant After Completing Extensive Maintenance and Upgrades

Need To Know: Analysts Are Much More Bullish On Aemetis, Inc. (NASDAQ:AMTX) Revenues

Consensus revenue estimates increase by 12%

Aemetis, Inc.'s RNG Production Facility Receives EPA Approval for D3 RNG Generation

First quarter 2023 earnings released: US$0.72 loss per share (vs US$0.54 loss in 1Q 2022)

Price target decreased by 16% to US$10.14

Investors Aren't Entirely Convinced By Aemetis, Inc.'s (NASDAQ:AMTX) Revenues

Forecast breakeven date pushed back to 2025

Consensus EPS estimates fall by 32%

Price target decreased by 8.7% to US$12.04

Consensus EPS estimates fall by 79%

Full year 2022 earnings released: US$3.12 loss per share (vs US$1.54 loss in FY 2021)

Price target decreased by 14% to US$13.18

Aemetis Biogas Accepts Digesters, 36 mile Pipeline and RNG Upgrade Facility as Placed In Service and Fully Operational

Price target decreased to US$15.71

Price target increased to US$21.50

Third quarter 2022 earnings released: US$2.01 loss per share (vs US$0.55 loss in 3Q 2021)

American Power Group and Aemetis Biogas Conduct Multiple California Demonstrations of American Power Group's V6000 Low-Carbon Dual Fuel Solution for Class 8 Trucks

Aemetis wins $7B worth of fuel supply contracts

Consensus forecasts updated

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

Aemetis GAAP EPS of -$0.01 beats by $0.35, revenue of $65.9M beats by $6.58M

Aemetis, Inc. announced delayed 10-Q filing

Aemetis: Waiting For Signs Of Profitability

Aemetis, Inc., Annual General Meeting, May 26, 2022

Forecast breakeven date pushed back to 2024

Consensus estimates of losses per share improve by 15%

Independent Director recently sold US$424k worth of stock

Independent Director notifies of intention to sell stock

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

Lead Independent Director exercised options to buy US$1.5m worth of stock.

Lead Independent Director exercised options to buy US$1.5m worth of stock.

Third quarter 2021 earnings released: US$0.55 loss per share (vs US$0.59 loss in 3Q 2020)

Lead Independent Director exercised options and sold US$372k worth of stock

Executive VP & COO recently sold US$120k worth of stock

Price target decreased to US$28.33

Consensus forecasts updated

Second quarter 2021 earnings released: US$0.34 loss per share (vs US$0.11 profit in 2Q 2020)

Price target decreased to US$31.17

Executive VP & MD notifies of intention to sell stock

Aemetis inks $200M deal for low carbon biofuels

Aemetis Present the Aemetis Corporate Presentation, Serve on the “Future of Energy” Panel

Independent Director notifies of intention to sell stock

Aemetis nabs second U.S. patent for using waste forest wood to produce high value biofuels

Aemetis Notified of US Forest Service Grant for Patented Process Enabling Use of Waste Wood for the ‘Carbon Zero’ Jet/Diesel Plant